Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.

扩大屏障预防措施对减少 VA 中艰难梭菌感染的影响。

基本信息

  • 批准号:
    10641758
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-01 至 2024-09-30
  • 项目状态:
    已结题

项目摘要

Background: Each year approximately 1.7 million occur in the United States causing significant morbidity and nearly 100,000 deaths. Clostridium difficile infection (CDI) has become the most common healthcare- associated infection (HAI) in U.S. hospitals causing half a million infections and 30,000 deaths. CDI ranges from asymptomatic colonization, mild to severe diarrhea, pseudomembranous colitis, toxic megacolon, colonic perforation, and death. Risk factors for CDI include older age, comorbidity, hospitalization, exposure to others with CDI, and antibiotic use. The increasing incidence of C. difficile and emergence of new epidemic strain has resulted in outbreaks in healthcare settings. Prevention of healthcare-onset (HO) CDI has quickly become a priority for most hospitals. Hospital prevention measures are limited to modifiable risk factors (i.e., prudent antibiotic use and limiting exposure to C. difficile). Hospital exposure to C. difficile can occur directly (i.e., hands or clothing of healthcare workers) or indirectly (i.e., environmental surfaces or shared equipment) so infection prevention measures focus on healthcare worker hand hygiene, healthcare worker barrier precautions (i.e., use of gowns and gloves) and cleaning and disinfection of the hospital environment and reusable medical equipment. However, these interventions are limited to symptomatic patients who test positive for CDI. Asymptomatic patients serve as a reservoir for cross contamination, but microbiological screening for asymptomatic carriage of C. difficile is not routinely performed in healthcare. Gloving for all patient contacts may interrupt transmission from asymptomatic patients colonized with C. difficile. Objectives: The overall purpose of the proposed study is to determine the effectiveness of healthcare worker use of gloves for all patient contact for reducing acquisition of C. difficile and hospital-onset CDI in inpatient hospital units. The main objective of the study is to compare the effects of universal gloving for all patient contact to the current standard of care (i.e., glove and gown only for known CDI cases). The specific aims are 1) Compare the effects of universal gloving for all patient contact to the current standard of care on C. difficile acquisition rates in hospitalized patients; 2) Compare the effects of universal gloving compared to standard of care gloving on CDI rates, other healthcare-associated infections, 30-day mortality and unit length of stay; 3) Evaluate intervention fidelity, the cost and stakeholder experiences. Methods: The study will be a cluster randomized trial (CRT) in ten inpatient VA hospital units. In the pre- intervention period we will conduct preparatory work including recruiting hospitals, training research assistants, securing IRB approval, identifying current practices, finalizing monitoring and observation plans and measuring baseline C. difficile acquisition rates. This will be followed by an intervention period executing the CRT in which hospital units will be randomized either to implement barrier precautions for all patient contacts or continue standard care (i.e., barrier precautions for patients with known CDI). The intervention will consist of all healthcare workers (nurses, providers, respiratory therapist, radiology and laboratory technicians, etc.) utilizing gloves for all patient contacts in the units that are randomized to receive the intervention. The non-intervention units will follow standard of care which consists of healthcare workers following barrier precautions (i.e., gloves and gowns) only for patients with known CDI and other antibiotic-resistant organisms (e.g., MRSA). The unit of analysis is the ICU, since data are collected at the level of the unit. Monthly data will be collected from all participating sites including C. difficile acquisition and infection rates, mortality, length of stay, barrier precaution compliance and end-user perceptions. Impact: The anticipated impact on Veterans’ healthcare is primarily the reduction of C. difficile acquisition and subsequent infection and its associated morbidity, mortality and costs. If found to be effective, the results will change the paradigm for CDI prevention in healthcare settings.
背景:美国每年大约有 170 万起此类事件,造成严重的发病率和 近10万人死亡。艰难梭菌感染(CDI)已成为最常见的医疗保健- 美国医院的相关感染 (HAI) 导致 50 万人感染和 3 万人死亡。 CDI范围 从无症状定植、轻度到重度腹泻、伪膜性结肠炎、中毒性巨结肠、结肠 穿孔、死亡。 CDI 的危险因素包括年龄较大、合并症、住院治疗、与他人接触 与 CDI 和抗生素的使用。艰难梭菌发病率的增加和新流行菌株的出现 导致医疗机构爆发疫情。预防医疗保健发病 (HO) CDI 已迅速成为一项 大多数医院的优先考虑。医院预防措施仅限于可改变的风险因素(即谨慎的 抗生素的使用和限制艰难梭菌的暴露)。医院可能会直接接触艰难梭菌(即, 医护人员的手或衣服)或间接(即环境表面或共用设备),以便 感染预防措施重点关注医护人员手部卫生、医护人员屏障预防措施 (即使用隔离衣和手套)以及医院环境的清洁和消毒以及可重复使用的医疗器械 设备。然而,这些干预措施仅限于 CDI 检测呈阳性的有症状患者。 无症状患者是交叉污染的储存库,但微生物筛查 艰难梭菌的无症状携带在医疗保健中并不常规进行。为所有患者接触者佩戴手套 可能会中断艰难梭菌定植的无症状患者的传播。 目标:拟议研究的总体目的是确定医护人员的有效性 在所有与患者接触的过程中使用手套,以减少住院患者感染艰难梭菌和医院发病的 CDI 医院单位。该研究的主要目的是比较通用手套对所有患者的影响 接触当前的护理标准(即仅在已知的 CDI 病例中使用手套和长袍)。具体目标是 1) 比较所有接触患者的通用手套与当前艰难梭菌护理标准的效果 住院患者的感染率; 2) 比较通用手套与标准手套的效果 护理手套了解 CDI 发生率、其他医疗保健相关感染、30 天死亡率和单位住院时间; 3) 评估干预的保真度、成本和利益相关者的体验。 方法:该研究将是在 10 个住院 VA 医院单位进行的整群随机试验 (CRT)。在预 干预期我们将进行准备工作包括招募医院、培训研究助理、 获得 IRB 批准、确定当前做法、最终确定监测和观察计划并进行测量 基线艰难梭菌采集率。接下来是执行 CRT 的干预期,其中 医院单位将被随机分配,要么对所有患者接触者实施屏障预防措施,要么继续 标准护理(即对已知 CDI 患者采取屏障预防措施)。干预措施将包括所有 医护人员(护士、提供者、呼吸治疗师、放射科和实验室技术人员等)利用 为随机接受干预的单位中的所有患者接触者戴上手套。不干预 单位将遵循护理标准,其中包括医护人员遵循屏障预防措施(即戴手套 和长袍)仅适用于已知患有 CDI 和其他抗生素耐药微生物(例如 MRSA)的患者。单位为 分析是 ICU,因为数据是在单位级别收集的。每月数据将从所有 参与地点包括艰难梭菌获得和感染率、死亡率、住院时间、屏障 预防措施合规性和最终用户的看法。 影响:对退伍军人医疗保健的预期影响主要是减少艰难梭菌的获取和 随后的感染及其相关的发病率、死亡率和费用。如果发现有效的话,结果将 改变医疗机构中 CDI 预防的范式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NASIA SAFDAR其他文献

NASIA SAFDAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NASIA SAFDAR', 18)}}的其他基金

BCCMA: Targeting Gut-Microbiome in Veterans Deployment related Gastrointestinal and Liver diseases; CMA5- Functional metagenomics in GWI-related gut dysfunction
BCCMA:针对退伍军人部署相关胃肠道和肝脏疾病中的肠道微生物组;
  • 批准号:
    10588620
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
扩大屏障预防措施对减少 VA 中艰难梭菌感染的影响。
  • 批准号:
    9720132
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Effect of Expanding Barrier Precautions for Reducing Clostridium difficile Acquisition in VA.
扩大屏障预防措施对减少 VA 中艰难梭菌感染的影响。
  • 批准号:
    10404905
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Reducing VA Healthcare-Associated Infections through Antibiotic StEwardship (RAISE)
通过抗生素管理减少 VA 医疗保健相关感染 (RAISE)
  • 批准号:
    10181069
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Identification of novel MDR antimicrobials from human microbiome symbioses
从人类微生物组共生体中鉴定新型耐多药抗菌药物
  • 批准号:
    10571221
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Identification of novel MDR antimicrobials from human microbiome symbioses
从人类微生物组共生体中鉴定新型耐多药抗菌药物
  • 批准号:
    10592388
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
Mentored Enhanced Implementation and Evaluation of National VA Mandates To Prevent The Spread Of C Difficile infection
指导加强国家退伍军人管理局指令的实施和评估,以防止艰难梭菌感染的传播
  • 批准号:
    10216348
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Fecal Microbiota Transplant for C. difficile Infection in Solid Organ Transplant Recipients
实体器官移植受者粪便微生物群移植治疗艰难梭菌感染
  • 批准号:
    10462715
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
氟喹诺酮类药物限制用于预防艰难梭菌感染 (CDI)_FIRST 试验。
  • 批准号:
    9753142
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Fluoroquinolone Restriction for the Prevention of C. difficile Infection (CDI)_the FIRST Trial.
氟喹诺酮类药物限制用于预防艰难梭菌感染 (CDI)_FIRST 试验。
  • 批准号:
    10165788
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了